Caesar J. Belbel

2012

In 2012, Caesar J. Belbel earned a total compensation of $1M as Executive Vice President, Chief Legal Officer and Secretary at ZIOPHARM Oncology, a 11% increase compared to previous year.

Compensation breakdown

Bonus$56,875
Option Awards$437,970
Salary$325,000
Stock Awards$219,448
Other$569
Total$1,039,862

Belbel received $438K in option awards, accounting for 42% of the total pay in 2012.

Belbel also received $56.9K in bonus, $325K in salary, $219.4K in stock awards and $569 in other compensation.

Rankings

In 2012, Caesar J. Belbel's compensation ranked 5,960th out of 11,487 executives tracked by ExecPay. In other words, Belbel earned more than 48.1% of executives.

ClassificationRankingPercentile
All
5,960
out of 11,487
48th
Division
Manufacturing
2,115
out of 4,253
50th
Major group
Chemicals And Allied Products
528
out of 1,198
56th
Industry group
Drugs
360
out of 920
61st
Industry
Pharmaceutical Preparations
285
out of 700
59th
Source: SEC filing on April 30, 2014.

Belbel's colleagues

We found four more compensation records of executives who worked with Caesar J. Belbel at ZIOPHARM Oncology in 2012.

2012

Jonathan Lewis

ZIOPHARM Oncology

Chief Executive Officer

2012

Jason Amello

ZIOPHARM Oncology

Chief Financial Officer

2012

Hagop Youssoufian

ZIOPHARM Oncology

Chief Medical Officer

2012

Richard Bagley

ZIOPHARM Oncology

Chief Financial Officer

You may also like